Home Blog of Signal Transduction ER stress & UPR IRE1 Utilizing inner filter effect in resonance Rayleigh scattering technique: a case study with silver nanocubes as RRS probe and several analytes as absorbers

Category

Archives

Popular Post

ESKM, a novel therapeutic agent for sensitive and resistant PH+ leukemias

The mechanism of resistance to JAK2 inhibitor in myeloproliferative neoplasms patients

Effects of PARP inhibitors in BRCA gene-mutated ovarian cancer

DASATINIB; An inhibitor of Receptor Tyrosine Kinase

GP130/JAK/STAT3 signaling pathway induces multiple myeloma

Utilizing inner filter effect in resonance Rayleigh scattering technique: a case study with silver nanocubes as RRS probe and several analytes as absorbers

It was demonstrated that the mechanism of the inner filter effect (IFE) can emerge well in the resonance Rayleigh scattering (RRS) technique and be utilized as a new analytical method in the design of innovative IFE-based sensors. To prove this process, silver nanocubes (Ag NCs) with tunable extinction spectra were selected as RRS probes, and three analytes, doxorubicin (DOX), sunitinib (SUN), and Alizarin Red S (ARS), were considered as the typical absorbers. In addition, in the presence of SUN as a typical analyte, the quenching of the RRS signal of Ag NCs, with λmax of 419 nm, was linear in the range 0.01 to 2.5 µM of SUN. The limit of detection (LOD) was 0.0025 µM. The introduced method was then used to develop a dual-signal assay for the ratiometric determination of Al3+ ions. The suggested dual-signal assay was based on the color changes of ARS caused by Al3+ and the IFE between ARS and Ag NCs. The obtained results showed that the two characteristics of response sensitivity and linear dynamic range are very satisfactory for sensing Al3+ ions. The findings of this study demonstrate that the newly developed IFE mechanism can be employed as an attractive and highly efficient analytical technique for measuring different analytes.

Related Products

Cat.No. Product Name Information
S1042 Sunitinib malate Sunitinib malate is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM in cell-free assays, and also inhibits c-Kit. Sunitinib Malate effectively inhibits autophosphorylation of Ire1α. Sunitinib Malate increases both death receptor and mitochondrial-dependent apoptosis.

Related Targets

IRE1 VEGFR c-Kit Apoptosis related Mitophagy PDGFR